Katrina Thornber, Author at European Medical Journal - Page 44 of 50

New Study Advances Personalised Prostate Cancer Treatments

A new trial has evaluated and personalised treatments for metastatic castration-resistant prostate cancer, representing a major advancement in treatment options for the disease.

Low-Impact Yoga Eases Urinary Incontinence Symptoms

A study comparing pelvic floor yoga and general exercise found both effective in reducing urinary incontinence in women, with no significant difference between the two approaches.

Temperature Extremes Worsen Raynaud’s Symptoms in Systemic Sclerosis

A study revealed that the severity of Raynaud’s phenomenon, a common early manifestation of systemic sclerosis, is influenced significantly by ambient temperature.

New Approach for Preventing Uveitis Relapse in Behçet's Disease

A study compared the effectiveness of three immunomodulatory therapies combined with corticosteroids in preventing uveitis relapse in patients with severe Behcet’s disease.

The Breast Cancer Index as a Tool for Tailoring Endocrine Therapy

The Breast Cancer Index effectively predicts outcomes and benefits of ovarian function suppression therapy in premenopausal women with HR+ breast cancer.

Researchers Identify Optimal Mammography Frequency for Improved Outcomes

Research shows annual mammograms lower late-stage breast cancer risk and improve survival compared to less frequent screening

SHAM-PVI Trial Confirms Efficacy of Ablation Procedure for Atrial Fibrillation: ESC 2024

ESC 2024: The SHAM-PVI trial confirms that catheter ablation significantly reduces atrial fibrillation burden and improves quality of life compared to a sham treatment.

Optical Coherence Tomography for Stent Guidance Improves Outcomes in Complex PCI Cases: ESC 2024

ESC 2024: OCT-guided PCI in complex lesions reduced cardiac risks by 38% and spontaneous MI by 64% versus angiography, according to the OCCUPI trial.

Wearable ECG Device for Atrial Fibrillation Screening: ESC 2024

Atrial fibrillation screening using a 14-day wearable heart monitor patch significantly increased diagnoses compared to usual care, according to research presented at ESC 2024.

Could AI Diagnose Coronary Artery Disease? ESC 2024

The PROTEUS trial, presented at ESC 2024, evaluated the effectiveness of AI in standardizing clinician decision-making during stress echocardiography for coronary artery disease